Literature DB >> 15548862

Specificity of blebbistatin, an inhibitor of myosin II.

John Limouze1, Aaron F Straight, Timothy Mitchison, James R Sellers.   

Abstract

Blebbistatin is a small molecule inhibitor discovered in a screen for inhibitors of nonmuscle myosin IIA. We have examined the specificity and potency of the drug by assaying its effects on the actin-activated MgATPase assay of diverse members of the myosin superfamily. Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 values ranging from 0.5 to 5 microM. Interestingly, smooth muscle which is highly homologous to vertebrate nonmuscle myosin is only poorly inhibited (IC50=80 microM). The drug potently inhibits Dictyostelium myosin II, but poorly inhibits Acanthamoeba myosin II. Blebbistatin did not inhibit representative myosin superfamily members from classes I, V, and X.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548862     DOI: 10.1007/s10974-004-6060-7

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  19 in total

1.  Kinetic mechanism of non-muscle myosin IIB: functional adaptations for tension generation and maintenance.

Authors:  Fei Wang; Mihaly Kovacs; Aihua Hu; John Limouze; Estelle V Harvey; James R Sellers
Journal:  J Biol Chem       Date:  2003-04-17       Impact factor: 5.157

2.  Functional divergence of human cytoplasmic myosin II: kinetic characterization of the non-muscle IIA isoform.

Authors:  Mihály Kovács; Fei Wang; Aihua Hu; Yue Zhang; James R Sellers
Journal:  J Biol Chem       Date:  2003-07-07       Impact factor: 5.157

3.  In vitro actin filament sliding velocities produced by mixtures of different types of myosin.

Authors:  G Cuda; E Pate; R Cooke; J R Sellers
Journal:  Biophys J       Date:  1997-04       Impact factor: 4.033

4.  Purification and characterization of smooth muscle myosin light chain kinase.

Authors:  R S Adelstein; C B Klee
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

Review 5.  A millennial myosin census.

Authors:  J S Berg; B C Powell; R E Cheney
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

6.  Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function.

Authors:  Aihua Hu; Fei Wang; James R Sellers
Journal:  J Biol Chem       Date:  2002-09-16       Impact factor: 5.157

Review 7.  Multiple effects of 2,3-butanedione monoxime.

Authors:  L C Sellin; J J McArdle
Journal:  Pharmacol Toxicol       Date:  1994-06

8.  Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle.

Authors:  H Higuchi; S Takemori
Journal:  J Biochem       Date:  1989-04       Impact factor: 3.387

9.  Neck length and processivity of myosin V.

Authors:  Takeshi Sakamoto; Fei Wang; Stephan Schmitz; Yuhui Xu; Qian Xu; Justin E Molloy; Claudia Veigel; James R Sellers
Journal:  J Biol Chem       Date:  2003-05-11       Impact factor: 5.157

10.  2,3-Butanedione monoxime (BDM) as a myosin inhibitor.

Authors:  E Michael Ostap
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 3.352

View more
  172 in total

1.  Functional Sindbis virus replicative complexes are formed at the plasma membrane.

Authors:  Elena I Frolova; Rodion Gorchakov; Larisa Pereboeva; Svetlana Atasheva; Ilya Frolov
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

2.  Extracellular signal-regulated kinase and GEF-H1 mediate depolarization-induced Rho activation and paracellular permeability increase.

Authors:  Faiza Waheed; Pam Speight; Glenn Kawai; Qinghong Dan; András Kapus; Katalin Szászi
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-17       Impact factor: 4.249

3.  Blebbing confers resistance against cell lysis.

Authors:  E B Babiychuk; K Monastyrskaya; S Potez; A Draeger
Journal:  Cell Death Differ       Date:  2010-07-02       Impact factor: 15.828

4.  Real-time monitoring of cell elasticity reveals oscillating myosin activity.

Authors:  Hermann Schillers; Mike Wälte; Katarina Urbanova; Hans Oberleithner
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

5.  Effects of actin-myosin kinetics on the calcium sensitivity of regulated thin filaments.

Authors:  Nicholas M Sich; Timothy J O'Donnell; Sarah A Coulter; Olivia A John; Michael S Carter; Christine R Cremo; Josh E Baker
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

6.  Effect of elevated intracellular cAMP levels on actomyosin contraction in bovine trabecular meshwork cells.

Authors:  Charanya Ramachandran; Rajkumar V Patil; Najam A Sharif; Sangly P Srinivas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

7.  Azidoblebbistatin, a photoreactive myosin inhibitor.

Authors:  Miklós Képiró; Boglárka H Várkuti; Andrea Bodor; György Hegyi; László Drahos; Mihály Kovács; András Málnási-Csizmadia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

8.  Blebbistatin: use as inhibitor of muscle contraction.

Authors:  Gerrie P Farman; Kittipong Tachampa; Ryan Mateja; Olivier Cazorla; Alain Lacampagne; Pieter P de Tombe
Journal:  Pflugers Arch       Date:  2007-11-10       Impact factor: 3.657

9.  Dopamine D4 Receptors Regulate GABAA Receptor Trafficking via an Actin/Cofilin/Myosin-dependent Mechanism.

Authors:  Nicholas M Graziane; Eunice Y Yuen; Zhen Yan
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

10.  ROCK Inhibition Promotes the Development of Chondrogenic Tissue by Improved Mass Transport.

Authors:  Kuo-Chen Wang; Thomas T Egelhoff; Arnold I Caplan; Jean F Welter; Harihara Baskaran
Journal:  Tissue Eng Part A       Date:  2018-04-23       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.